{
    "code": "02022647",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022647",
    "time": "2015-08-23 11:28:53",
    "許可證字號": "衛署藥輸字第022647號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/05\/31",
    "註銷理由": "屆期未申請展延",
    "有效日期": "93\/10\/22",
    "發證日期": "88\/10\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202264700",
    "中文品名": "泰胃美錠２００公絲",
    "英文品名": "TAGAMET HB 200MG TABLETS",
    "適應症": "十二指腸潰瘍、胃潰瘍、胃酸過多、逆流性食道炎、急性糜爛性胃炎所致的上胃腸道出血。",
    "劑型": "110錠劑",
    "包裝": "鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "CIMETIDINE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1115901100  荷商葛蘭素史克藥廠股份有限公司臺灣分公司",
    "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
    "主製造廠": {
        "製造廠名稱": "F370024000  SMITHKLINE BEECHAM PHARMACEUTICALS CO.",
        "製造廠廠址": "ROAD 172 KM 9.1 P.O. BOX 11975 CIDRA PUERTO RICO 00739-1975",
        "製造廠公司地址": "",
        "製造廠國別": "PUERTO RICO",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640000500",
            "成分名稱": "CIMETIDINE",
            "含量描述": "200",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ]
}